Khalid Shah
Affiliations: | Harvard Medical School, Boston, MA, United States |
Area:
Therapeutic and diagnostic stem cells for neurological disordersGoogle:
"Khalid Shah"Mean distance: 106866
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Vogiatzi I, Lama LM, Lehmann A, et al. (2024) Allogeneic stem cells engineered to release interferon β and scFv-PD1 target glioblastoma and alter the tumor microenvironment. Cytotherapy |
Choi SH, Tamura K, Khajuria RK, et al. (2024) Antiangiogenic Variant of TSP-1 Targets Tumor Cells in Glioblastomas. Molecular Therapy : the Journal of the American Society of Gene Therapy |
Choi SH, Tamura K, Khajuria RK, et al. (2024) Antiangiogenic Variant of TSP-1 Targets Tumor Cells in Glioblastomas. Molecular Therapy : the Journal of the American Society of Gene Therapy. 32: 1595 |
Choi SH, Stuckey DW, Pignatta S, et al. (2024) Editor's Note: Tumor Resection Recruits Effector T Cells and Boosts Therapeutic Efficacy of Encapsulated Stem Cells Expressing IFNβ in Glioblastomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 30: 1993 |
Liu L, van Schaik TA, Chen KS, et al. (2024) Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice. Frontiers in Immunology. 14: 1324618 |
Moleirinho S, Kitamura Y, Borges PSGN, et al. (2023) Fate and Efficacy of Engineered Allogeneic Stem Cells Targeting Cell Death and Proliferation Pathways in Primary and Brain Metastatic Lung Cancer. Stem Cells Translational Medicine |
Kanaya N, Kitamura Y, Lopez Vazquez M, et al. (2023) Gene-edited and -engineered stem cell platform drives immunotherapy for brain metastatic melanomas. Science Translational Medicine. 15: eade8732 |
van Schaik TA, Moreno-Lama L, Aligholipour Farzani T, et al. (2023) Engineered cell-based therapies in ex vivo ready-made CellDex capsules have therapeutic efficacy in solid tumors. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 162: 114665 |
Chen KS, Reinshagen C, Van Schaik TA, et al. (2023) Bifunctional cancer cell-based vaccine concomitantly drives direct tumor killing and antitumor immunity. Science Translational Medicine. 15: eabo4778 |
Bhere D, Choi SH, van de Donk P, et al. (2022) Target receptor identification and subsequent treatment of resected brain tumors with encapsulated and engineered allogeneic stem cells. Nature Communications. 13: 2810 |